Hyperion Therapeutics Balance Sheet - Annual (NASDAQ:HPTX)

Add to My Stocks
$45.99 $0.02 (0.04%) HPTX stock closing price May 07, 2015 (Closing)

The financial analysis of a company like Hyperion Therapeutics involves checking the three financial statements of the company in detail, of which the balance sheet is one. Balance sheet items like cash at hand, total assets and liabilities helps one analyze a company and summarize the financial performance of the company like we have in our Hyperion Therapeutics stock analysis. A company releases its balance sheet every year along with its annual results. The Hyperion Therapeutics balance sheet for 2014 shows total assets of $180.41M. The company has a asset turnover ratio of . Also see: Hyperion Therapeutics revenue and Hyperion Therapeutics operating cash flow for the same year.

View latest 10 year balance sheet data to check Hyperion Therapeutics financial performance.
show more
Fiscal year is Jan - Dec20142013201220112010
Cash102.79M74.23M49.85M7.32M-
Marketable Securities34.48M28.04M---
Receivables14.86M4.41M---
Inventory4.62M3.51M---
Raw Materials1.78M----
Work In Progress-----
Finished Goods2.29M2.81M---
Notes Receivable-----
Other Current Assets2.63M1.4M1.15M--
Total Current Assets
159.4M111.61M51M8.06M-
Property Plant & Equipment1.75M1.2M---
Accumulated Depreciation-----
Net Property Plant & Equipment
1.11M----
Investment & Advances9.22M15.78M---
Other Non-Current Assets-----
Deferred Charges-----
Intangibles8.81M13.44M---
Deposits & Other Assets1.85M----
Total Assets
180.41M142.51M51.2M8.14M-
Notes Payable-5.65M4.34M23.41M-
Accounts Payable4.66M2.29M2.17M1.88M-
Current Portion Long-Term Debt-----
Current Portion Capital Leases-----
Accrued Expenses25.5M12.18M2.54M3.31M-
Income Taxes Payable-----
Other Current Liabilities-----
Total Current Liabilities
30.4M20.13M9.06M29.34M-
Mortgages-----
Deferred Taxes/Income-----
Convertible Debt-----
Long-Term Debt18.12M2.62M7.75M--
Non-Current Capital Leases-----
Other Long-Term Liabilities---2.57M-
Total Liabilities
48.86M22.83M16.81M31.92M-
Minority Interest-----
Preferred Stock---58.32M-
Common Stock Net-----
Capital Surplus260.22M242.1M173.38M24.63M-
Retained Earnings-128.62M-122.37M-138.99M-106.73M-
Treasury Stock-----
Other Liabilities-0.05M-0.05M---
Shareholders Equity131.55M119.68M34.38M-23.77M-
Total Liabilities & Shareholders Equity180.41M142.51M51.2M8.14M-
All figures in USD. M: Millions of USD, B: Billions of USD.

Click here to view our Neogen financial analysis

Looking at Hyperion Therapeutics historical stock prices and the current Hyperion Therapeutics stock price can tell you how the stock price has moved, whereas the Hyperion Therapeutics PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: An asset is a resource that a corporation like Hyperion Therapeutics owns and has monetary significance. HPTX assets grew from $142.51M in 2013 to $180.41M in 2014. Assets can be of two types: fixed assets like real estate, plant and machinery; and current assets which includes cash, accounts receivable etc. Tech stocks typically don't have too many assets.
  • Liabilities: The total liabilities of Hyperion Therapeutics for the year 2014 total to $48.86M. Liabilities for a company like Hyperion Therapeutics include bank loans, services which have been availed for which a settlement in the form of cash/ asset transfer needs to be done in future etc. A firm takes on such obligations to grow its business which in turn will generate future economic benefits for its business.

Annual Balance Sheets For Hyperion Therapeutics Inc Peers

Furiex Pharmaceuticals balance sheet, Neuroderm balance sheet, Neogen balance sheet